ABSTRACT. IL-1 receptor antagonist (IGlra) is a cytokine that blocks the effects of I G 1 by binding to I G 1 receptors without inducing signal transduction. Amniotic fluid contains high concentrations of IGlra. The purpose of this study was I ) to analyze whether factors related to the mother or the fetus influence amniotic fluid I G l r a concentration, and 2) to study whether the fetus is a source of IGlra. Two hundred two specimens of amniotic fluid, as well as 21 urine samples from newborn infants, were analyzed. Women carrying a female fetus had a higher concentration of amniotic fluid I G l r a than those carrying a male fetus (female 136.4 f 6.1 pg/L, n = 83; male 74.7 
f 3.7 pg&, n = 119; p c 0.0001, unpaired two-sided t test). Length of gestation, presence or absence of labor signs, or elevated I G l B in amniotic fluid did not affect the concentration of I G l r a in amniotic fluid. Urine of infants taken during the first 48 h of life contained a high concentration of I G l r a (91.1 + 17.5 pg/L). The urinary I G l r a concentration was higher in female newborns than in male newborns (females 124.0 + 25.2 pg/L, n = 11; males 54.9 f 19.1 pg/L, n = 10; p = 0.04). We conclude that I ) the concentration of I G l r a in amniotic fluid and newborn urine is dependent on the gender of the fetus and of the newborn and 2) fetal urine is a major source of amniotic fluid I G Ira. The higher I G l r a in female-bearing gestations may contribute to the better resistance of female fetuses against Dreterm birth and ~erinatal infections. (Pediatr Res 35: 130-134,1994) Abbreviations duction (6) . IL-1 ra has been shown to block various IL-1 -induced responses on many cells (6) , including inflammatory changes caused by IL-1 (7) . Exogenous administration of IL-1 ra reduces mortality in animal models of sepsis or endotoxemia (8) (9) (10) (11) (12) .
Preterm labor is strongly associated with intraamniotic infection (13) . Bacterial products such as endotoxin stimulate the production of IL-1 by decidual macrophages (14) . I L 1 stimulates the production of prostaglandins, major inducers of uterine contractions, by amnion and decidua (1 5, 16). The concentration of this cytokine is elevated in amniotic fluid in women in preterm labor with microbial invasion of the amniotic cavity (17) . In addition, administration of IL-1 to animals induces preterm labor (1 8). For these reasons, IL-1 has been proposed to act as a mediator in preterm labor occumng in the setting of infection (19) . IL-lra, on the other hand, inhibits the IL-1-stimulated prostaglandin production by amnion cells (20, 21) . It also prevents preterm delivery induced in mice by IL-1 (22) .
Human amniotic fluid has been reported to contain high IL1ra concentrations (20) . This may be of importance in the defense of the fetoplacental unit against inflammatory conditions mediated by IL-I (20) (21) (22) . No patient-related factor is known to affect IL-lra concentration in amniotic fluid. The source of amniotic fluid IL-lra is likewise unknown. The purpose of this study was 1 ) to analyze whether factors related to the mother or the fetus influence the concentration of I L Ira in amniotic fluid, and 2) to study whether the fetus could be a source of IL-lra.
SUBJECTS AND METHODS
Informed consent was obtained from the pregnant patients IL-lra, I G 1 receptor antagonist and the parents of the infants participating in the-study.-~ll the PROM, premature rupture of the membranes amniocenteses were performed for diagnostic purposes. Amnioticfluid samples. Altogether 202 pregnant women participated in the study; one sample was obtained from each patient. Patient characteristics are shown in Table 1 . One hundred thirty-one samples were obtained at a gestational age IL-1 indicates two structurally related cytokines, IL-la and less than 37 wk. Twenty-nine samples were from women in IL-lfi, that n~ediate many ~h~siologic responses to infection and labor; 173 were from women without signs of labor. Five patients infli~mmation (1). IL-la and IL-lfi act through the same cell were in preterm labor (i.e. labor at gestational age less than 37 Surface receptors and share biologic activities (1). IL-1 induces completed wk). One hundred eighty-three samples were obtained fever, sleep, anorexia, and hypotension (1). It also i~~r e a s e s the transabdominally. Nineteen samples were recovered from the synthesis of collagenases and prostaglandins, and stimulates the vaginal pool; all of these were from patients in labor at term. production of several inflammatory mediators (2) (3) (4) (5) .
Urine samples. Urine samples of 10 preterm neonates (gesta-IL-lra is a c~tokine that is structurally related to and tional ages between 27 and 37 wk) and of 1 1 term neonates were IL-lfi (6) . IL-lra Opposes the IL-I competing wth analyzed for IL-lra. All the samples were collected during the IL-1 for binding to IL-1 receptors without inducing signal trans-first 48 of life. The diagnostic categories of the infants were as ing four patient groups: normal, preterm PROM, maternal diabetes, and miscellaneous (Fig. 3) .
Concentration of IL-la in amnioticPuid. Amniotic fluid ILl/3 was not associated with fetal gender. As expected (20) , it was not associated with amniotic fluid IL-lra, either. In patients with PROM at gestational age of less than 34 weeks, amniotic fluid IL-la concentration was 84.9 f 48.7 ng/L (14) , and amniotic fluid IL-lra concentration was 133.3 f 19.9 pg/L (n = 15). In patients without PROM of similar gestational age, IL-IS was above the detection limit only in two (concentrations 9.8 and 4.5 ng/L) of a total of 3 1 specimens ( p = 0.0 15 vs. PROM), but the concentration of IGlra was similar (108.2 + 9.3 pg/L, n = 3 1, p = 0.20) to that in patients with PROM.
Concentration of IL-lra in urine at birth: gender dependence. All urine samples collected before 48 h of age from preterm and term neonates contained IL-1 ra. The mean IL-lra in newborn urine was 91.1 * 17.5 (n = 21), with a range from 5.0 to 297.1
d L .
The concentration of IL-lra in neonatal urine was higher in female newborns than in male newborns ( p = 0.04) ( Table 3 ). The gestational ages and birth weights of the female and male neonates were similar.
I L 1 ra in neonatal urine was not dependent on gestational age. The urinary concentration of IL-1 ra was 7 1.7 f 25.6 pg/L (range 5.0-203 pg/L) in preterm neonates (gestational age less than 37 wk, n = 10) and 108.7 f 23.7 pg/L (range 19.7-297 pg/L) in term neonates (n = 1 1). 
DISCUSSION
The present results show that women carrying a female fetus have a higher concentration of IL-Ira in amniotic fluid than women carrying a male fetus. To our knowledge, sex-specific differences in the concentration of IL-lra in any body fluids have not previously been reported.
IL-Ira was present in the urine of newborn infants in very high concentrations, comparable to those in amniotic fluid. An important source of amniotic fluid IL-lra is therefore likely to be fetal urine, the major contributor to amniotic fluid volume. Because keratinocytes contain considerable amounts of IL-1 ra (24) and cells from fetal skin are desquamated to amniotic fluid, fetal skin is another possible source of amniotic fluid IL-lra. In addition, fetal membrane and decidual cells release IL-lra in vitro and may thus also contribute to amniotic fluid IL-l ra (2 1, 25).
As a preliminary finding, we report here that IL-lra concentration in the urine of female newborns tends to be higher than in male newborns. Most of the infants studied were suffering from severe diseases. A study involving a larger number of patients including normal newborns is needed before any definite conclusion can be drawn regarding the gender dependence of ILIra concentration in the urine of newborn infants.
There are limited data available on the concentration of ILIra in body fluids, and no reports have been published on the concentration of IL-1 ra in urine or sera of newborns or children. IL-Ira is present in urine of patients with fever or myelocytic leukemia (26) (27) (28) . After experimental endotoxemia in human volunteers, IL-l ra concentrations in plasma increased from 0.46 to 15 pg/L (29) . In critically ill patients, plasma IL-lra has been reported to range from 0.32 to 55 pg/L (29) . IL-lra concentration in serum of patients with Hodglun's disease ranges from 0.63 to 16 pg/L (30). The concentrations found in amniotic fluid or in urine of newborn infants thus greatly exceed those reported previously in the sera or plasma of adults.
IL-1 is a mediator in both local and systemic infections. Furthermore, it has functions in host defense mechanisms, particularly immunologic and hematologic responses (1). It induces fever, decreases blood pressure, lowers systemic vascular resistance, induces neutrophilia, and increases the synthesis of collagenases (1). IL-1 up-regulates the production of other mediators such as platelet-activating factor, prostaglandins, and nitric oxide (5). IL-1 can also induce its own production and that of other cytokines that participate in inflammatory processes (2-4, 3 1,  32 ). In addition, the growth of virulent strains of Escherichia coli is enhanced by IL-l (33) .
IL-l ra alleviates inflammatory effects of IL-1 (7). It inhibits the production of cytokines induced by IL-1 (34, 35) . In animal models, treatment with IL-lra improves survival in Escherichia coli (9), Staphylococcus epidermidis (12), and polymicrobial Gram-negative sepsis (lo), as well as in endotoxemia (8, 1 1) . ILIra is endogenously produced in response to endotoxemia and septic shock (29) . Production of IL-lra can be considered a host defense mechanism to block deleterious effects of IL-1 (5). The balance between the amount of IL-1 and the amount of IL-lra may be a critical factor in determining whether the host is able to block the symptoms mediated by IL-1.
Male newborns have increased risks of infection-mediated morbidity and mortality (36-4 1) . Thus, male newborns are two to six times more likely to develop perinatal sepsis or meningitis than female newborns (36) (37) (38) . The risk of perinatal bacterial infection after PROM is also higher in male than in female fially afectinn concentration of IL-1 ra in amniotic. neonates (40). Amniotic fluid invaded by microorganisms is an important source of fetal and perinatal infections (42-44). Infection leads to activation of the cytokine network and to increased production of cytokines such as IL-1 (1 7). IL-1 mediates s y m p toms and signs of infection. IL-l ra has been shown to reduce the severity of diseases such as hemodynamic shock and lethal sepsis (8-12). Endogenously produced IL-1 ra may similarly prevent the onset and development of inflammatory lesions. Amniotic fluid IL-Ira concentration is constitutively high, as shown by present and previous (20) results. Fetal skin is exposed to IL-Ira present in amniotic fluid. Through swallowing of amniotic fluid and fetal breathing, the gastrointestinal tract and the airways of the fetus are also exposed to IL-lra. The increased concentration of IL-Ira in the amniotic fluid surrounding female fetuses and the increased production of IL-l ra by female fetuses and newborns may contribute to the better resistance to infection of female compared with male fetuses and newborns. However, at present there is no direct evidence indicating that high endogenous IL-Ira protects against severe infections.
A higher incidence of prematurity in male births than in female births has been documented in several studies (45-48). According to one study, males are more likely than females to be born at 33 to 36 wk of gestation (48). Other studies have found an excess of male births at gestational ages between 24 and 37 wk (45-47). Due to its presence in amniotic fluid in preterm labor occumng in the setting of infection and its stimulatory effects on fetal membrane prostaglandin synthesis, IL-I has been proposed to act as a mediator of preterm labor (1 9). IL-lra inhibits the IL-1-induced prostaglandin production by human amnion cells (20, 21). In mice, preterm delivery induced by IL-I can be blocked by IL-Ira (22). A high IL-Ira in fetal urine and amniotic fluid may inhibit IL-1-induced inflammatory changes in the fetal membranes and in the fetus. The higher IL-l ra concentration in amniotic fluid surrounding the female fetus and bathing her fetal membranes may be one factor contributing to the lower incidence of infections and preterm deliveries among female fetuses.
The sources of IL-1 ra in the fetus and newborn infant and the regulation of its production remain to be elucidated. The possibility that, in addition to IL-Ira, other cytokines are gender dependent merits investigation.
